Supplementary Figure 1 from Immunotherapy Inhibits Tumor Cholesterol Synthesis via the IFNγ–IRF1–SREBF2 Axis
Abstract
Supplementary Figure 1. The RNA-sequencing analysis for IFN-γ-treated B16 cells
Fields of Study & Subjects
Cancer
Lipids
and Metabolism
Cancer Immunotherapy and Biomarkers
Cholesterol and Lipid Metabolism
Publication details
- Publication date
- 4 March 2026
- Language
- EN